We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correction |

Omitted Acknowledgment FREE

JAMA. 2000;284(24):3129. doi:10.1001/jama.284.24.3129.
Text Size: A A A
Published online

In the Original Contribution entitled "Postlicensure Safety Surveillance for Varicella Vaccine" published in the September 13, 2000, issue of THE JOURNAL (2000;284:1271-1279), several contributors to the data from the Vaccine Adverse Event Reporting System (VAERS) were omitted from the Acknowledgment. During the primary analysis period (March 1995 through July 25, 1998) the Columbia University laboratory of Drs Phillip LaRussa, Sharon Steinberg, and Anne Gershon conducted the polymerase chain reaction and restriction fragment length polymorphism analyses to identify varicella-zoster virus and to distinguish the vaccine strain from wild-type strains. They worked under contract to the Varicella Zoster Virus Identification Program at Merck & Co Inc. VAERS received the results of these analyses from Merck as individual case reports. Although the article mentioned that the National Varicella Reference Laboratory at the Centers for Disease Control and Prevention performs these analyses, during the time covered by the study only the Columbia University laboratory had this capability. In cooperation with the Centers for Disease Control and Prevention, Merck also operates the varicella vaccine pregnancy registry, where Kristine Shields provided detailed information about multiple cases.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.